XPO (NYSE: XPO), a leading provider of freight transportation in North America, today announced that its Board of Directors ...

Corporation announced that its Board of Directors has authorized a new share repurchase program under which the company may ...

Anaptys has cash, cash equivalents and investments greater than $420 million as of December 31, 2024, and anticipates receipt of a $75 million commercial sales milestone payment from GSK in 2025 or ...

Shares of AnaptysBio (NASDAQ: ANAB) climbed 12% today as the company announced a significant stock repurchase plan, signaling confidence in its financial position and future prospects. The ...

The Stock Repurchase Plan will expire on December 31, 2025, may be suspended or discontinued at any time, and does not obligate the company to acquire any amount of common stock. This press ...

Thursday announced that its Board of Directors has determined to resume repurchases of shares of the company’s common stock.

Engine Capital, which said it owns about 9.8% of Civeo’s shares, urged the company’s board of directors to make a series of ...

The Stock Repurchase Plan will expire on December 31, 2025, may be suspended or discontinued at any time, and does not obligate the company to acquire any amount of common stock. This press release ...